Log In
BCIQ
Print this Print this
 

ATA 842, NINA 842

  Manage Alerts
Collapse Summary General Information
Company Atara Biotherapeutics Inc.
DescriptionFully human mAb
Molecular Target Myostatin (MSTN) (GDF8)
Mechanism of ActionMyostatin (GDF-8) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCachexia
Indication DetailsTreat cancer cachexia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today